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Abstract
Colonic crypts are stereotypical structures with distinct stem cell, proliferating, and differentiating compartments. Colorectal
cancers derive from colonic crypt epithelia but, in contrast, form morphologically disarrayed glands. In this study, we
investigated to which extent colorectal cancers phenocopy colonic crypt architecture and thus preserve structural
organization of the normal intestinal epithelium. A subset of colon cancers showed crypt-like compartments with high WNT
activity and nuclear b-Catenin at the leading tumor edge, adjacent proliferation, and enhanced Cytokeratin 20 expression in
most differentiated tumor epithelia of the tumor center. This architecture strongly depended on growth conditions, and
was fully reproducible in mouse xenografts of cultured and primary colon cancer cells. Full crypt-like organization was
associated with low tumor grade and was an independent prognostic marker of better survival in a collection of 221
colorectal cancers. Our findings suggest that full activation of preserved intestinal morphogenetic programs in colon cancer
requires in vivo growth environments. Furthermore, crypt-like architecture was linked with less aggressive tumor biology,
and may be useful to improve current colon cancer grading schemes.
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Introduction
Colorectal cancer (CRC) derives from normal colonic mucosa
by a well characterized, stepwise accumulation of mutations that
transform normal epithelial cells into tumor cells with malignant
behavior [1]. Normal colonic mucosa is quite simply organized,
basically as a sheet of epithelial cells with infoldings forming
stereotypical crypts [2]. Each crypt contains distinct functional
compartments with stem cells at the crypt base, responsible for
continuous renewal of aged epithelial cells, a proliferating transit
amplifying zone extending to the mid crypt, and most mature
epithelial cells towards the crypt apex [3]. Experimental data,
mainly derived from murine small intestinal crypts, suggest high
canonical WNT signaling activity within the stem cell compart-
ment at the crypt base [4,5], while mature cells at the crypt apex
are characterized by expression of differentiation markers, such as
Cytokeratin 20 (CK20) [6].
In contrast to normal colonic mucosa, the structural organiza-
tion of CRC is much less well understood. CRCs form tumor
masses rather than sheets of cells, with varying degrees of
morphologically disarrayed epithelial glands [7]. However, these
tumors do not appear to be completely unorganized. A gradient
between less differentiated tumor cells at the leading tumor edge,
and more glandular differentiated cells in the tumor center can be
observed in most CRCs [8,9]. In addition, tumor cells at the
leading tumor edge typically express strong nuclear b-Catenin,
indicating high WNT signaling activity, and have been disputed to
represent a progenitor cell population of operationally defined
colon cancer stem cells [10,11]. On the contrary, expression of
CK20 was suggested to label more differentiated colon cancer
cells, since its expression was mutually exclusive with putative
colon cancer stem cell markers [11,12]. Collectively, these data
suggest some degree of structural organization within CRC, with
cancer stem cells at the leading tumor edge and differentiation
towards the tumor center.
Considering these findings and known compartments within
intestinal crypts, we herein investigated, to which extent CRCs
phenocopy normal colonic crypts. We categorize the degree of
crypt-like architecture in a colorectal cancer case collection with
long term follow-up data and demonstrate that in vitro and in vivo
growth conditions strongly influence on this structural organiza-
tion.
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Materials and Methods
Histology and Immunohistochemistry
Formalin fixed, paraffin embedded normal human colonic
mucosa, primary CRC tissues, xenograft tumors, and Matrigel
embedded tumor cell spheroids were cut into 5 mm sections,
deparaffinized, and antigens were retrieved in TRS6 (Dako
Cytomation) for 20 min in a microwave oven. Adherent cultures
of Caco2 and SW1222 cells were grown on cover slips, fixed in
formalin, and permeabilized in 2% TritonX-100. Slides or cover
slips then were incubated sequentially with mouse anti-b-Catenin
(BD Transduction Laboratories; 1:200), rabbit anti-KI67 (Cell
Signaling; 1:200) and goat anti-CK20 (Santa Cruz Biotechnology;
1:50) for 1 h each at room temperature, washed with PBS, and
then with FITC conjugated donkey anti-goat (Jackson ImmunoR-
esearch; 1:200), AlexaFluor 555 conjugated goat anti-mouse, and
AlexaFluor 405 conjugated goat anti-rabbit (Invitrogen; 1:500).
For visualization of nuclear b-Catenin in normal colonic crypts,
nuclei were counterstained with DAPI (Vector Laboratories).
Confocal fluorescence images were taken on a LSM 700 laser
scanning microscope using the ZEN software (Carl Zeiss). For
conventional and double immunostaining, prediluted mouse anti-
b-Catenin (Ventana Medical Systems) and/or mouse anti-CK20
(Progen; 1:200) were used, and staining was performed on a
Ventana Benchmark XT autostainer with ultraView Universal
DAB and alkaline phosphatase detection kits (Ventana Medical
Systems). Isotype-controls were included for all antigens.
Cell culture and mouse xenografts
Caco2 cells were purchased from the American Type Culture
Collection and SW1222 cells were obtained from the Ludwig
Institute for Cancer Research (New York, USA). Adherent cell
cultures were grown in Dulbecco’s Modified Eagle’s Medium
(DMEM, Biochrom), supplemented with 10% fetal bovine serum,
1% glutamine, and 1x Penicillin-Streptomycin. Spheroid cultures
were grown in StemPro hESC SFM medium in the presence of
20 ng/ml EGF and 10 ng/ml bFGF (Life Technologies) in ultra-
low attachment flasks (Corning). Vital tissue of a sporadic primary
colon adenocarcinoma was acquired through the Stiftung Human
Tissue & Cell Research (HTCR, München, Germany), disaggre-
gated into single cell suspensions using collagenase IV (Worthing-
ton Biomedical) and DNase I (Sigma-Aldrich), as previously
described [10], and expanded in spheroid cultures. For further
analyses, spheroids of cell lines and primary tumor cells were
harvested by centrifugation at 200 g, resuspended in Matrigel,
fixed in paraformaldehyde, and then sandwiched between
HistoGel layers (ThermoScientific) for paraffin embedding. For
xenograft growth, 106 cells from adherent cell cultures or 105
spheroid-derived primary colon cancer cells were suspended in
100 ml of a 1:1 mixture of PBS and growth factor-depleted
Matrigel (BD Bioscience) before subcutaneous injection into 6–8
week old NOD/SCID (NOD.CB17-Prkdcscid, The Jackson
Laboratory) mice. Animals were housed in pathogen free micro-
isolator cages and sacrificed when xenografts reached a diameter
of 1 cm. Xenograft tumors then were removed, formalin fixed,
and paraffin embedded. Three independent xenografts were
subjected to further investigation for each cell line or primary
tumor. Experimental procedures using animals were reviewed and
approved by the Regierung von Oberbayern.
CRC specimen collection and statistics
CRC specimens from patients that underwent intentionally
curative surgical resection between 1994 and 2006 at the LMU
were drawn from the archives of the institute of pathology. Follow-
up data were recorded by the Munich Cancer Registry. Specimens
and data were anonymized, and the need for consent was waived
by the institutional ethics committee of the Medical Faculty of the
LMU. Inclusion criteria were localized colorectal adenocarcino-
mas with absence of nodal (N0) or distant metastasis (M0) at the
time of diagnosis (UICC stage I and II). Tumor tissues were
assembled into tissue microarrays (TMAs) with 6 representative
1 mm cores, including tumor edges and tumor centers of each
case. The final collection consisted of 221 CRC cases of which in
41 cases (19%) patients had died of their tumor within the follow-
up period. Survival data were censored when case follow-up was
discontinued or patients had died of reasons other than CRC.
Case characteristics are summarized in Table 1. TMA slides then
were subjected to single and double stainings for b-Catenin and
CK20, as described above. Whole tissue sections of individual
cases with heterogeneous b-Catenin and CK20 distribution were
used for triple immune fluorescence analyses. Cancer specific
survival was analyzed by the Kaplan-Meier method and groups
were compared with the log-rank test. Statistics were calculated
using SPSS (IBM).
Results
Crypt-like functional compartments and axis formation in
colorectal cancer
To visualize different functional compartments within normal
colonic crypts and CRCs, we established triple immune fluores-
cence stainings for b-Catenin, proliferation- related Ki-67 antigen
(KI67) and Cytokeratin 20 (CK20). As expected, confocal imaging
of normal colonic crypts indicated WNT active compartments
with nuclear expression of b-Catenin at the crypt base, a KI67
expressing transit amplifying zone of proliferating epithelial
progenitors, and most differentiated epithelial cells expressing
CK20 towards the crypts’ apices (Figure 1A). Notably, visualiza-
tion of weak but distinct nuclear b-Catenin at the crypt base
required high magnifications and slight nuclear counterstaining
(Figure 1A, Figure S1). We then subjected primary CRCs to the
same triple staining protocol. Similar to previous findings [8,9],
strong nuclear expression of b-Catenin was confined to tumor cells
at the leading tumor edge and included morphologically
undifferentiated colon cancer cells infiltrating surrounding stromal
tissue (Figure 1B). Interestingly, and on the contrary to nuclear b-
Catenin, CK20 staining was most intense in more central and
glandular differentiated tumor epithelia, neighboring tumor
necrosis (Figure 1B). KI67 was found between these zones and
was reduced in tumor cells with strong CK20 expression
(Figure 1B). These findings indicated that, despite disarrayed
gland formation, colon cancers preserve some degree of structural
organization and axis formation found in normal colonic crypts.
Xenograft models of colon cancers reproduce the full
spectrum of crypt-like organization
Next, we analyzed a primary colon cancer and colon cancer cell
lines under different growth conditions in vitro and in vivo.
Adherent in vitro cell cultures of SW1222 and Caco2 colon cancer
cell lines revealed some degree of tumor cell heterogeneity for
nuclear b-Catenin, KI67 and CK20 that was more prominent in
low density than in confluent cultures (Figures 2A-D). Low density
SW1222 cultures also exhibited some rudimentary centripetal axis
formation with slightly enhanced CK20 expression and reduced
KI67 proliferation within the colony centers, and stronger nuclear
b-Catenin staining at the colony edge (Figure 2A). In Caco2 cells,
differential expression of CK20 and nuclear b-Catenin appeared
more randomly distributed (Figure 2C). To assess whether three
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dimensional growth would yield higher degrees of structural
organization and tumor cell heterogeneity in vitro, we cultured
both cell lines and primary colon cancer cells as non-adherent
spheroids. Similar to our findings in adherent cultures, we
observed some tumor cell heterogeneity for all three markers
(Figures 2E-G). However, although primary colon cancer spheres
showed slight centripetal axis formation with enhanced central
CK20 staining (Figure 2G), no full structural organization, as we
had found in primary colon cancer tissue, was observed. We then
injected both cell lines and primary colon cancer cells into immune
compromised mice for subcutaneous tumor formation in vivo. On
the contrary to our in vitro findings, these tumors formed
glandular structures with full degrees of tumor cell heterogeneity
and distinct nuclear b-Catenin, KI67 and CK20 positive
compartments (Figures 2H-J), mimicking those found in primary
CRCs, and reminiscent of normal colonic crypt architecture.
Collectively, these findings indicated that three dimensional
growth and surrounding stromal tissue are required to expose full
tumor cell heterogeneity and axis formation in CRCs.
Classification and clinical relevance of crypt-like
organization in colorectal cancers
To determine the frequency of crypt-like organization in CRCs,
we used a case collection of 221 primary tumors and applied
double immune staining for b-Catenin and CK20, marking both
extremes of normal colonic crypt compartments. Analyses of these
cases revealed 5 different types of colon cancers: The largest group
(type A) showed organized expression of nuclear b-Catenin at the
leading tumor edge and enhanced CK20 within the tumor center
(Figure 3). Of note however, when examining cases of this type on
serial sections, we observed additional enhanced CK20 expression
in most infiltrative tumor cells at the leading tumor edge,
overlapping with nuclear b-Catenin in most of these cases (Figure
S2). The other tumors lacked this organization to some degree
(Figure 3), either by absence of nuclear b-Catenin (type B),
absence of enhanced CK20 in the tumor center (type C), absence
of decreased nuclear b-Catenin in the tumor center (type D), or
absence of both nuclear b-Catenin and CK20 expression (type E).
We then examined these types for associations with tumor specific
survival. Interestingly, Kaplan-Meier plots revealed best outcome
for CRCs with full crypt-like structural organization, based on
nuclear b-Catenin and CK20 expression (type A) that was
significantly better, when statistically tested against all other types
combined (Figure 4). We then examined type A tumors for
associations with other clinical variables and found a significant
correlation with low tumor grade, while there was no significant
association with other variables such as age, gender and T
category (Table 1). Finally, when testing type A tumors against
others for survival prediction in multivariate analyses, full
structural organization proved to be an independent prognostic
marker for better cancer specific survival (Table 2). These findings
demonstrate that CRCs mimic crypt-like compartments and axis
formation to varying degrees and implicate that high structural
similarity to normal colonic crypts may be associated with less
aggressive tumor behavior.
Discussion
Here, we demonstrate that CRCs phenocopy normal colonic
crypt architecture. In contrast to normal crypts, these tumors grow
invasively and form morphologically disarrayed glands [7].
However, distinct compartments with high WNT activity at the
leading tumor edge, adjacent proliferation, and enhanced CK20
expression towards the tumor center can be identified. Since
normal colonic crypts have a known WNT driven stem cell
compartment at their base, maturing into epithelial cells with
strong CK20 expression at the apex [4–6], our findings support
the idea of colon cancers mimicking these functional compart-
ments, with colon cancer stem cells at the leading tumor edge, and
centripetal tumor cell differentiation, as was previously hypothe-
sized [13]. However, our data also indicate significant discrepan-
cies to normal colonic crypt architecture, since not all CRCs
Table 1. Clinicopathological variables and association with crypt-like type A morphology in colorectal cancer.
Characteristics Total Type A tumor p
yes no
All patients 221 (100) 75 (33.9) 146 (66.1)
Age (y, median 69)
#68 110 (49.8) 40 (18.1) 70 (31.7) 0.45
$69 111 (50.2) 35 (15.8) 76 (34.4)
Gender
Male 121 (54.8) 45 (20.4) 76 (34.4) 0.26
Female 100 (45.2) 30 (13.6) 70 (31.7)
Tumor size (UICC)
T1 1 (0.5) 0 (0) 1 (0.5) 0.61
T2 36 (16.3) 15 (6.8) 21 (9.5)
T3 176 (79.6) 58 (26.2) 118 (53.4)
T4 8 (3.6) 2 (0.9) 6 (2.7)
Tumor grade (WHO)
low grade 200 (90.5) 72 (32.6) 128 (57.9) 0.046
high grade 21 (9.5) 3 (1.4) 18 (8.1)
Percent values are given in parentheses.
doi:10.1371/journal.pone.0104284.t001
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showed the full range of crypt-like compartmentalization. More-
over, CRCs with discernable compartments frequently showed
enhanced CK20 not only in central tumor areas but additionally
at the leading tumor edge, coinciding with strong nuclear b-
Catenin and high WNT activity. While these findings implicate
that morphogenetic programs of intestinal epithelial cells are still
active in colorectal cancers to some extent, markers for terminal
differentiation in the normal intestine may not necessarily be
restricted to fully differentiated tumor cells of intestinal neoplasms.
Figure 1. Colorectal cancers phenocopy normal colonic crypt architecture. Triple immune staining for b-Catenin (bCat), KI67 and CK20. (A)
Colonic crypts show nuclear b-Catenin expression at their base, KI67 extending to the mid crypt, and CK20 at the apex. Visualization of nuclear b-
Catenin required counterstaining with DAPI and high magnification (left panel inset). Red and blue bars delineate crypt parts with and without
nuclear b-Catenin, respectively. (B) Colorectal cancers display a similar organization with nuclear b-Catenin at the tumor edge (arrowheads), CK20
expression in the tumor center (arrows), and KI67 in between. Scale bars, 100 mm.
doi:10.1371/journal.pone.0104284.g001
Figure 2. Impact of different culture conditions on colon cancer architecture. Triple immune staining reveals lack of full structural
organization in adherent tissue cultures of (A) low density and (B) confluent SW1222, and (C) low density and (D) confluent Caco2 colon cancer cells,
as well as in spheroid cultures of (E) SW1222, (F) Caco2, and (G) primary colon cancer cells. On the contrary, subcutaneous xenografts of (H) SW1222,
(I) Caco2, and (J) primary colon cancer cells form glands with organized expression of nuclear b-Catenin at the tumor edge (arrowheads) and CK20
expression in the tumor center (arrows). Scale bars, 100 mm.
doi:10.1371/journal.pone.0104284.g002
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Comparing different culture and growth conditions of colon
cancer cells, we observed fully developed and compartmentalized
glandular structures in in vivo xenograft tumors only. Recapitu-
lation of structures, imitating normal colonic crypt architecture
and full gradient formation of least and most differentiated colon
cancer cells, may therefore require signaling from a tumor
Figure 3. Types of colorectal cancer as defined by nuclear b-Catenin and CK20 expression. Double immune staining for b-Catenin (brown)
and CK20 (red). (Type A) Full structural organization with nuclear b-Catenin at the tumor edge (arrowhead) and CK20 within the tumor center
(arrow). (Type B) Absence of nuclear b-Catenin. (Type C) Absence of central CK20. (Type D) Absence of decreased nuclear b-Catenin in the tumor
center. (Type E) Absence of both nuclear b-Catenin and CK20. Frequencies of these types are given in the table.
doi:10.1371/journal.pone.0104284.g003
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microenvironment [8,14], missing in standard culture systems.
These findings have important implications for studies that focus
on specific tumor cell subpopulations, since tumor cell composition
in regular or spheroid cultures may not adequately reflect the
situation in primary tumors. Interestingly however, when grown as
xenograft tumors, even established colon cancer cell lines formed
fully developed crypt-like structures and compartmentalization,
similar to primary colon cancers. This suggests that, despite some
expected genetic alterations in passaged cell lines [15], using colon
cancer cell line xenografts may not be inferior to the use of
primary colon cancers for studies on tumor cell subpopulations,
such as colon cancer stem cells [12,16]. In this context, growth
conditions in vivo may be more relevant than the source of the
colon cancer cell, either derived from established cultures or
primary tumors.
When looking at associations with clinical parameters, we linked
crypt-like structural organization of CRCs to improved survival
and low tumor grade. While prognosis of these tumors can best be
estimated by staging, describing extent of the disease [17],
histopathological tumor grading has independently been linked
with disease outcome and reflects the overall degree of tumor cell
differentiation [18]. Several grading systems based on different
aspects of tumor morphology have been proposed, however, due
to poor reproducibility, a simplified two-tiered system, only
considering gland formation, is currently favored, and classifies
these tumors into low and high grade neoplasms [19]. Although
this grading system is widely accepted and regarded as a consistent
prognostic factor by the College of American Pathologists, it does
not integrate existence and distribution of distinct tumor cell
subpopulations that may impact on prognosis. On the other hand,
recently emerging approaches to assess CRC prognosis, such as
stem cell marker expression [20,21] or microRNA profiling [22],
so far either lack general acceptance or have the caveat of being
costly and technically demanding. Since in our study, crypt-like
organization served well in predicting disease outcome, we
propose that this approach may integrate morphological aspects
of gland formation with markers indicating functional tumor
compartments. b-Catenin and CK20 expression can be robustly
assessed in colon cancer specimens and integration of these
parameters into routine diagnostics may therefore improve
histopathological colon cancer grading. In addition to these
considerations, our findings may also explain previous inconsistent
Figure 4. Type A colorectal cancers are associated with better survival. (A) Kaplan-Meier plot for the different types of colorectal cancers, as
indicated by letters on curves. (B) Type A colorectal cancer patients (upper curve) show significantly (log-rank test) better survival when compared to
other types (lower curve). Ratios on curves indicate the number of events over the number of patients per group.
doi:10.1371/journal.pone.0104284.g004
Table 2. Multivariate analysis of cancer specific survival.
Variables Cancer specific survival
HR (95% confidence interval) p
Age (y) 2.0 (1.02–3.81) 0.045
Gender 1.2 (0.63–2.36) 0.55
T category 3.5 (1.40–8.55) 0.007
Tumor grade 1.3 (0.53–2.97) 0.6
Type A tumor 0.5 (0.21–0.998) 0.049
doi:10.1371/journal.pone.0104284.t002
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data on clinical correlates of nuclear b-Catenin [23,24], tumor cell
proliferation [25,26], and CK20 expression in colon cancer
[27,28]. If these markers indicate functional and structural
compartments within these tumors, it is possible that compartment
organization is more relevant to tumor biology and reflected in
clinical outcome than simple compartment size.
Supporting Information
Figure S1 Increased WNT-activity at the base of normal
colonic crypts. While b-Catenin labels epithelial cell mem-
branes as part of adherens junctions, high magnifications indicate
additional nuclear b-Catenin expression at the crypt base (black
arrowheads). Lack of nuclear expression with dominance of blue
counterstaining is seen in epithelial cells above the crypt base (blue
arrowheads). Left panel shows higher magnification of area boxed
in right panel.
(TIF)
Figure S2 CK20 expression is not limited to the tumor
center of type A colorectal cancers. Serial sections
demonstrate, in addition to enhanced CK20 staining in the tumor
center (arrows), enhanced staining for CK20 at the tumor edge,
overlapping with nuclear b-Catenin (arrowheads). This pattern
was found in 61% of type A colorectal cancers.
(TIF)
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